Hi Tony,
In Hashans' article he states the average price for an orphan drug in 2017 was US$187k. I think this is a good guide given we are treating an unmet need and the robustly positive results in the P3 trial. I have no experience in this matter but logically thinking i believe the price will likely be around that mark. It could be well more however i dont see it being much below that price guide.
Trof Pricing - name your price, page-16
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.56 |
Change
-0.050(0.32%) |
Mkt cap ! $1.956B | |||
| Open | High | Low | Value | Volume |
| $15.83 | $15.87 | $15.20 | $6.318M | 408.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 169 | $15.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.56 | 332 | 6 |
View Market Depth
| Last trade - 15.52pm 16/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |